Literature DB >> 23632866

Venous thromboembolism in ENT surgery: a review of the literature and completed audit cycle of adherence to national guidance.

Raj Lakhani1, Vishal Narwani, Adam Bromby, Andreas W Hilger.   

Abstract

Venous thromboembolism (VTE) risk assessment of elective ENT patients is essential to minimize the risk of mortality and morbidity. The study is standard-based audit of VTE risk assessment against the ENT UK guidelines and intervention includes instructional poster and departmental presentation. 23 patients on eight operating lists were audited in the first cycle (C1). A total of 27 patients on ten operating lists were re-audited in the second cycle (C2). There were marked improvements in the number of VTE risk assessments completed (C1 = 3/23; C2 = 26/27; p < 0.0001), the number of patients encouraged to mobilize (C1 = 0/23; C2 = 26/27; p < 0.0001), and the number of VTE leaflets provided upon discharge (C1 = 1/23; C2 = 27/27; p < 0.0001) following the intervention. The introduction of a poster and a departmental presentation proved to be simple, cheap, and effective measures to improve adherence of national VTE guidelines.

Entities:  

Mesh:

Year:  2013        PMID: 23632866     DOI: 10.1007/s00405-013-2505-1

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  23 in total

Review 1.  Audit and feedback: effects on professional practice and healthcare outcomes.

Authors:  Noah Ivers; Gro Jamtvedt; Signe Flottorp; Jane M Young; Jan Odgaard-Jensen; Simon D French; Mary Ann O'Brien; Marit Johansen; Jeremy Grimshaw; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 2.  Venous thromboembolism prophylaxis in gynecologic surgery: a systematic review.

Authors:  David D Rahn; Mamta M Mamik; Tatiana V D Sanses; Kristen A Matteson; Sarit O Aschkenazi; Blair B Washington; Adam C Steinberg; Heidi S Harvie; James C Lukban; Katrin Uhlig; Ethan M Balk; Vivian W Sung
Journal:  Obstet Gynecol       Date:  2011-11       Impact factor: 7.661

3.  Deep venous thrombosis and pulmonary embolism in otolaryngologic patients.

Authors:  William P Innis; Timothy D Anderson
Journal:  Am J Otolaryngol       Date:  2008-10-01       Impact factor: 1.808

Review 4.  Prophylaxis of venous thromboembolism in medical patients.

Authors:  A T Cohen; R Alikhan
Journal:  Curr Opin Pulm Med       Date:  2001-09       Impact factor: 3.155

Review 5.  The prevention of hospital-acquired venous thromboembolism in the United Kingdom.

Authors:  Beverley J Hunt
Journal:  Br J Haematol       Date:  2008-11-29       Impact factor: 6.998

6.  A prospective study of venous thromboembolism after major trauma.

Authors:  W H Geerts; K I Code; R M Jay; E Chen; J P Szalai
Journal:  N Engl J Med       Date:  1994-12-15       Impact factor: 91.245

7.  Incidence of deep venous thrombosis and pulmonary embolism in otolaryngology-head and neck surgery.

Authors:  E H Moreano; J L Hutchison; T M McCulloch; S M Graham; G F Funk; H T Hoffman
Journal:  Otolaryngol Head Neck Surg       Date:  1998-06       Impact factor: 3.497

8.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 9.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

10.  The need for venous thromboembolism (VTE) prophylaxis in plastic surgery.

Authors:  V Leroy Young; Marla E Watson
Journal:  Aesthet Surg J       Date:  2006 Mar-Apr       Impact factor: 4.283

View more
  1 in total

Review 1.  Implementation of study results in guidelines and adherence to guidelines in clinical practice.

Authors:  Frank Waldfahrer
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.